Product Name
Endothelin 3 (EDN3), Peptide
Full Product Name
Endothelin 3 (Big) (1-41) (rat) (Endothelin-3, EDN3, ET3, ET-3, MGC15067, MGC61498, Preproendothelin-3, PPET3)
Product Gene Name
EDN3 peptide
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Chromosome Location
Chromosome: 20; NC_000020.10 (57875499..57901047). Location: 20q13.2-q13.3
3D Structure
ModBase 3D Structure for P14138
Purity/Purification
Highly Purified
~95%. Purified by HPLC.
Form/Format
Supplied as a lyophilized powder.
Sequence (linear)
Cys-Thr-Cys-Phe-Thr-Tyr-Lys-Asp-Lys-Glu-Cys-Val-Tyr-Tyr-Cys-His-Leu-Asp-Ile-Ile-Trp-Ile-Asn-Thr-Pro-Glu-Gln-Thr-Val-Pro-Tyr-Gly-Leu-Ser-Asn-His-Arg-Gly-Ser-Leu-Arg-NH2
Preparation and Storage
Lyophilized powder may be stored at 4 degree C for short-term only. Stable for 12 months at -20 degree C. Reconstitute to nominal volume (see reconstitution instructions for peptides) and store at -20 degree C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.
Other Notes
Small volumes of EDN3 peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
EDN3 peptide
Endothelins (ET) show potent constrictor activity in vascular and non-vascular smooth muscle. This family of 21-amino acid peptides exists in at least three isoforms, ET-1, ET-2, and ET-3, and is produced in endothelial and epithelial cells. ET's can mediate
biological effects in cells and tissues, and have been shown to bind to an ET receptor in the lung, kidney, heart and liver.
Product Categories/Family for EDN3 peptide
Molecular Biology; MB-Peptides
NCBI/Uniprot data below describe general gene information for EDN3. It may not necessarily be applicable to this product.
NCBI Accession #
NP_996917.1
[Other Products]
NCBI GenBank Nucleotide #
NM_207034.1
[Other Products]
UniProt Primary Accession #
P14138
[Other Products]
UniProt Secondary Accession #
Q03229; Q7Z6D2; Q9UGT7; E1P5I5[Other Products]
UniProt Related Accession #
P14138[Other Products]
Molecular Weight
25,454 Da[Similar Products]
NCBI Official Full Name
endothelin-3 isoform 1 preproprotein
NCBI Official Synonym Full Names
endothelin 3
NCBI Official Symbol
EDN3 [Similar Products]
NCBI Official Synonym Symbols
ET3; ET-3; WS4B; HSCR4; PPET3
[Similar Products]
NCBI Protein Information
endothelin-3; preproendothelin-3
UniProt Protein Name
Endothelin-3
UniProt Synonym Protein Names
Preproendothelin-3
Protein Family
Endothelin
UniProt Gene Name
EDN3 [Similar Products]
UniProt Synonym Gene Names
ET-3; PPET3 [Similar Products]
UniProt Entry Name
EDN3_HUMAN
NCBI Summary for EDN3
The protein encoded by this gene is a member of the endothelin family. Endothelins are endothelium-derived vasoactive peptides involved in a variety of biological functions. The active form of this protein is a 21 amino acid peptide processed from the precursor protein. The active peptide is a ligand for endothelin receptor type B (EDNRB). The interaction of this endothelin with EDNRB is essential for development of neural crest-derived cell lineages, such as melanocytes and enteric neurons. Mutations in this gene and EDNRB have been associated with Hirschsprung disease (HSCR) and Waardenburg syndrome (WS), which are congenital disorders involving neural crest-derived cells. Four alternatively spliced transcript variants encoding three distinct isoforms have been observed. [provided by RefSeq, Jul 2008]
UniProt Comments for EDN3
Function: Endothelins are endothelium-derived vasoconstrictor peptides.
Subcellular location: Secreted.
Tissue specificity: Expressed in trophoblasts and placental stem villi vessels, but not in cultured placental smooth muscle cells. Ref.9
Involvement in disease: Hirschsprung disease 4 (HSCR4) [MIM:613712]: A disorder of neural crest development characterized by absence of enteric ganglia along a variable length of the intestine. It is the most common cause of congenital intestinal obstruction. Early symptoms range from complete acute neonatal obstruction, characterized by vomiting, abdominal distention and failure to pass stool, to chronic constipation in the older child.Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.14Congenital central hypoventilation syndrome (CCHS) [MIM:209880]: Rare disorder characterized by abnormal control of respiration in the absence of neuromuscular or lung disease, or an identifiable brain stem lesion. A deficiency in autonomic control of respiration results in inadequate or negligible ventilatory and arousal responses to hypercapnia and hypoxemia.Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.13Waardenburg syndrome 4B (WS4B) [MIM:613265]: A disorder characterized by the association of Waardenburg features (depigmentation and deafness) with the absence of enteric ganglia in the distal part of the intestine (Hirschsprung disease).Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.12 Ref.15 Ref.16
Sequence similarities: Belongs to the endothelin/sarafotoxin family.
Sequence caution: The sequence AAR16083.1 differs from that shown. Reason: Erroneous gene model prediction.
Research Articles on EDN3
1. Studies revealed hypermethylation of EDN2 and EDN3 genes in human primary colon cancers and in a panel of human colon cancer cell lines. Epigenetic inactivation of ET-2 and ET-3 occurs frequently in both rat and human colon cancers.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.